-
-
-
Inhaled apomorphine, at doses up to 0.8 mg, appears safe and well tolerated by patients with Parkinsons disease, but does not result in significant improvement in wearing off periods, at the tested doses.
-
In a survey of consecutive myeloma patients from the Mayo Clinic on hypothetical constructs with varying expectations regarding overall survival benefit, toxicity, and financial burden, it was found that the majority of patients would not choose maintenance if toxicity was more than just mild and overall survival benefit was less than 1 year. Increasing financial burden (drug cost) also reduced the numbers that would choose maintenance therapy. Males were more likely than females to choose treatment in each of the scenarios presented.
-
Curcumin, the primary active constituent of curcuma longa, is well known for its antioxidative and anti-inflammatory actions, but also has been used traditionally for conditions including depression and anxiety in Chinese and Ayurvedic medicine
-
The consequences of vitamin b12 (B12) deficiency most commonly include neurologic (CNS and peripheral nervous system) and hematologic (megaloblastic anemia).
-
A new drug for the treatment of neurogenic orthostatic hypotension (NOH) has been approved by the FDA under its accelerated approval program. Droxidopa is a prodrug to norepinephrine.
-
This study demonstrates an association between the use of hospitalists by a hospital and a reduction in 30-day excess readmission rates for heart failure, acute myocardial infarction, and pneumonia.
-
We now have three options for emergency contraception the copper IUD, oral ulipristal acetate, and oral levonorgestrel. One of the most important considerations in using emergency contraception is the initiation of ongoing regular contraception. The special feature will discuss the opportunities and considerations for use of these three different methods of postcoital contraception.
-
A meta-analysis of 19 studies involving first trimester screening for fetal anomalies has shown that a majority of major structural abnormalities can be diagnosed between 11 and 14 weeks and that even cardiac abnormalities can be identified with ultrasound with reasonable efficiency.
